News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Annovis Bio Inc.
Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
March 19, 2026
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
March 16, 2026
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
March 03, 2026
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease
February 12, 2026
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
December 18, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis to Host Corporate Update Webinar on January 28, 2026
December 16, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group
December 03, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Announces Two Presentations at the CTAD 2025 Conference
November 24, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study
November 18, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology to Accelerated Cognitive Decline in Parkinson's Patients
November 17, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results
November 12, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program
November 06, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Announces $3.4 Million Registered Direct Offering of Common Stock Priced At-the-Market under the NYSE Rules
October 27, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock
October 15, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Announces $6 Million Registered Direct Offering of Common Stock
October 10, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Announces Novel Biomarker Data in Alzheimer’s Patients Supporting Buntanetap’s Potential as a Disease-Modifying Treatment
October 09, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Appoints Mark Guerin as Chief Financial Officer
September 25, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
TRAW
Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap
September 16, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results
August 12, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Completes Full Patent Transfer to Crystal Buntanetap
August 07, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis to Attend the AAIC 2025 with Four Poster Presentations
June 26, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
June 19, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis to Host Webinar and Live Q&A on June 24, 2025
June 05, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results
May 13, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Bio Appoints Hui Liu as Director of Biostatistics
April 29, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
March 27, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program
March 25, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
March 21, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
March 11, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.